Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (5y) (2014 - 2026)
Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,338.00 |
| Dec 31, 2025 | -801.00 |
| Sep 30, 2025 | -514.00 |
| Jun 30, 2025 | -827.00 |
| Mar 31, 2025 | -2,479.00 |
| Dec 31, 2024 | -31,872.00 |
| Sep 30, 2024 | 2,981.00 |
| Jun 30, 2024 | -16,153.00 |
| Mar 31, 2024 | 1,011.00 |
| Dec 31, 2023 | 2,458.00 |
| Sep 30, 2023 | 1,559.00 |
| Jun 30, 2023 | 1,818.00 |
| Mar 31, 2023 | 1,269.00 |
| Dec 31, 2022 | 2,559.00 |
| Sep 30, 2022 | 10,466.00 |
| Jun 30, 2022 | 4,069.00 |
| Mar 31, 2022 | 1,173.00 |
| Dec 31, 2021 | 3,371.00 |
| Sep 30, 2021 | 5,772.00 |
| Jun 30, 2021 | -290.00 |